跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RISEDRONATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RISEDRONATE
Authorized
STANDARD
RISEDRONATE
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
676933d3863bd8ce
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
676933d3863bd8ce
Drug Approval Canada Name
RISEDRONATE
Product Name
RISEDRONATE
Status
Marketed
Status Date
2022-10-05
Original Market Date
2022-10-05
Din
02528460
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:24.00
Atc Original
M05BA07 RISEDRONIC ACID
Atc Name
m 05 ba 07
Aig Number
0135301005
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
676933d3863bd8ce
Type
Standard
Back to Health Canada Approvals